NEU is, without a shadow of a doubt, the stock with the absolute worst good-news-to-price-action correlation in the entire ASX, indeed the entire registry of any Godforsaken securities exchange in the known universe.
NEU could - and I say this with a straight face - get FDA approval to use trofinetide to treat cancer, AIDS, atopic dermatitis and ISS (Itchy Scrot Syndrome) on the same day and the share price would go backwards.
Ann: FDA grants Orphan for both Phelan-McDermid and Pitt Hopkins, page-10
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |